Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06476145 · ClinicalTrials.gov registry record
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
A clinical trial of Adenoma Colon Polyp, sponsored by AdventHealth.
- Recruiting
- Registry status
- 342
- Enrollment target
- 1
- Study location
NCT06476145 is a study of Adenoma Colon Polyp that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 342 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06476145, a study of Adenoma Colon Polyp, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
Conditions Studied
Study Locations (1)
Florida
- AdventHealth - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2023-12-08 |
| Est. Completion | 2027-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06476145
The ClinicalTrials.gov registry entry for NCT06476145 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adenoma Colon Polyp appearing as the primary indexed condition, and to 0 interventions.
NCT06476145 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06476145 about?
NCT06476145 is a clinical study titled "Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation". Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
What is the current status of trial NCT06476145?
This trial is currently recruiting. The enrollment target is 342 participants. The study started on 2023-12-08. Estimated completion is 2027-01-08.
What conditions does trial NCT06476145 study?
This clinical trial studies the following conditions: Adenoma Colon Polyp.
Who is sponsoring clinical trial NCT06476145?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06476145 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.